Overview

Value of Using Pioglitazone in Chronic Myeloid Leukemia Treatment

Status:
Completed
Trial end date:
2021-04-15
Target enrollment:
Participant gender:
Summary
Assessment of patients response and expression levels of CITED2 and HIF2a genes on adding pioglitazone to imatinib therapy.
Phase:
Phase 2
Details
Lead Sponsor:
Mansoura University
Treatments:
Pioglitazone